Aptose Biosciences Inc. (APTO)
USD 0.18
(-4.69%)
USD 0.18
(-4.69%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -45.4 Million | -32.32 Million | -43.3 Million | -33.89 Million | -21.55 Million | -23.2 Million |
| Net Income | -52.14 Million | -41.82 Million | -65.35 Million | -55.23 Million | -26.27 Million | -28.86 Million |
| Depreciation & Amortization | 474.54 Thousand | 528 Thousand | 622 Thousand | 614 Thousand | 613 Thousand | 87 Thousand |
| Deferred income taxes | -46.65 Million | - | -7000.00 | -8000.00 | -23 Thousand | 25 Thousand |
| Stock-based compensation | 3.65 Million | 5.2 Million | 12.94 Million | 21.43 Million | 2.29 Million | 4.27 Million |
| Change in working capital | 2.44 Million | 4.31 Million | 1.51 Million | -262 Thousand | 1.88 Million | 673 Thousand |
| Other non-cash items | 46.81 Million | -551 Thousand | 6.97 Million | -435 Thousand | -55 Thousand | 600 Thousand |
| Investing Cash Flow | 10.14 Million | 30.06 Million | -35.2 Million | 12.62 Million | -17.37 Million | 12 Thousand |
| Investments in PPE | -29.53 Thousand | -24 Thousand | -212 Thousand | -79 Thousand | -102 Thousand | -329 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | -34.99 Million | - | -17.26 Million | - |
| Sales/Maturities of investments | 10.17 Million | 30.09 Million | -34.99 Million | 12.7 Million | -17.26 Million | 341 Thousand |
| Other Investing Activities | -1.00 | 30.09 Thousand | 34.99 Million | 12.7 Thousand | 17.26 Million | 341.00 |
| Financing Cash Flow | 6.91 Million | 116 Thousand | 226 Thousand | 58.8 Million | 103.44 Million | 27.87 Million |
| Debt repayment | - | -546 Thousand | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | 29 Thousand | - | - | - | 4.37 Million | 1.92 Million |
| Common Stock Issuance | 7.03 Million | 101 Thousand | 36 Thousand | 58.4 Million | 105.85 Million | 26.44 Million |
| Other Financing Activities | 6.91 Million | 561 Thousand | 190 Thousand | 405 Thousand | 103.44 Million | 27.87 Million |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | -280 Thousand | 4.62 Million | -472 Thousand | 211 Thousand | 645 Thousand | 726 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | 2.72 Million | -310 Thousand | 1.98 Million | -473 Thousand | 1.24 Million | -53 Thousand |
| Cash at beginning of period | 36.95 Million | 39.11 Million | 117.39 Million | 79.84 Million | 15.29 Million | 10.63 Million |
| Cash at end of period | 9.2 Million | 36.97 Million | 39.11 Million | 117.39 Million | 79.84 Million | 15.29 Million |
| Capital Expenditure | -29.53 Thousand | -24 Thousand | -212 Thousand | -79 Thousand | -102 Thousand | -329 Thousand |
| Effect of forex changes on cash | 2000.00 | -4000.00 | 7000.00 | 7000.00 | 23 Thousand | -8000.00 |
| Net cash flow / Change in cash | -27.74 Million | -2.14 Million | -78.27 Million | 37.55 Million | 64.54 Million | 4.66 Million |
| Free Cash Flow | -45.43 Million | -32.34 Million | -43.51 Million | -33.97 Million | -21.66 Million | -23.53 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -7.25 Million | -9.59 Million | -12.28 Million | -52.14 Million | -11.44 Million | -14.12 Million |
| Depreciation & Amortization | 117.97 Thousand | 108.51 Thousand | 113.04 Thousand | 474.54 Thousand | 111 Thousand | 114 Thousand |
| Deferred income taxes | - | - | -637.07 Thousand | -46.65 Million | -10.04 Million | -11.22 Million |
| Stock-based compensation | 207 Thousand | 809 Thousand | 411 Thousand | 3.65 Million | 599 Thousand | 769 Thousand |
| Change in working capital | 1.05 Million | -3.06 Million | 2.13 Million | 2.44 Million | 223 Thousand | -317 Thousand |
| Other non-cash items | 488.08 Thousand | 1.05 Million | 760.29 Thousand | 46.81 Million | 10.02 Million | 11.28 Million |
| Investing Cash Flow | 1.97 Million | -1.98 Million | 1.99 Million | 10.14 Million | 12.95 Million | -1.96 Million |
| Investments in PPE | 17 Thousand | 1000.00 | -60.97 | -29.53 Thousand | 19.28 | -29 Thousand |
| Acquisitions | 16.88 Thousand | 995.53 | - | - | - | - |
| Investment purchases | 1.96 Million | -1.98 Million | 27.63 Thousand | - | 4.86 Million | -1.93 Million |
| Sales/Maturities of investments | 1.99 Million | -1.99 Million | 1.99 Million | 10.17 Million | 12.95 Million | -1.93 Million |
| Other Investing Activities | 2 Million | -1.99 Million | -0.03 | -1.00 | -4.86 Million | 1.93 Million |
| Financing Cash Flow | 4.8 Million | 11.79 Million | 854 Thousand | 6.91 Million | 4.9 Million | 1.1 Million |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | 29 Thousand | 29 Thousand | - | - |
| Common Stock Issuance | 4.98 Million | 11.79 Million | 882.39 Thousand | 7.03 Million | 4.85 Million | 1.12 Million |
| Other Financing Activities | -175.71 Thousand | 11.84 Million | 854 Thousand | 6.91 Million | 4.9 Million | 1.1 Million |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | 4.69 Million | -3.62 Million | 3.23 Million | -280 Thousand | -690 Thousand | -2.01 Million |
| Inventory | - | - | - | - | - | - |
| Other working capital | 1.05 Million | -3.06 Million | -1.09 Million | 2.72 Million | 690 Thousand | 2.01 Million |
| Cash at beginning of period | 7.33 Million | 9.2 Million | 15.64 Million | 36.95 Million | 8.4 Million | 22.76 Million |
| Cash at end of period | 8.32 Million | 7.33 Million | 9.2 Million | 9.2 Million | 15.72 Million | 8.4 Million |
| Capital Expenditure | 17 Thousand | 1000.00 | -60.97 | -29.53 Thousand | 19.28 | -29 Thousand |
| Effect of forex changes on cash | -1000.00 | 1000.00 | -1000.00 | 2000.00 | 1000.00 | -3000.00 |
| Net cash flow / Change in cash | 990.35 Thousand | -1.86 Million | -6.43 Million | -27.74 Million | 7.32 Million | -14.36 Million |
| Free Cash Flow | -5.8 Million | -11.7 Million | -9.5 Million | -45.43 Million | -10.53 Million | -13.53 Million |
ZFSVF
TPBI
LMR
6508
OC
0HM0